TY - JOUR
T1 - Evidence for direct regulation of myocardial Na+/H+ exchanger isoform 1 phosphorylation and activity by 90-kDa ribosomal S6 kinase (RSK)
T2 - Effects of the novel and specific RSK inhibitor fmk on responses to α1-adrenergic stimulation
AU - Cuello, Friederike
AU - Snabaitis, Andrew K.
AU - Cohen, Michael S.
AU - Taunton, Jack
AU - Avkiran, Metin
PY - 2007/3
Y1 - 2007/3
N2 - Multiple stimuli of physiological and pathophysiological significance, including α1-adrenoceptor agonists, stimulate the cardiac sarcolemmal Na+/H+ exchanger isoform 1 (NHE1) through activation of the mitogen-activated or extracellular signal-regulated kinase (ERK) kinase (MEK) ERK-90-kDa ribosomal S6 kinase (RSK) signaling cascade. However, the individual contributions of ERK and RSK, which can each phosphorylate the NHE1 regulatory domain, to such stimulation are unknown. In the present study, we have used the novel RSK inhibitor fmk to determine the role of RSK as a direct regulator of NHE1 phosphorylation and activity in response to α1-adrenergic stimulation, in ventricular myocytes isolated from the adult rat heart. Initial experiments confirmed that pretreatment of myocytes with fmk before exposure to the α1- adrenoceptor agonist phenylephrine inhibited RSK C-terminal kinase activity and thereby RSK N-terminal kinase activation, without affecting MEK or ERK activation. Pretreatment of myocytes with fmk also inhibited phenylephrine-induced increases in NHE1 phosphorylation and the rate of NHE1-mediated H+ efflux under conditions of intracellular acidosis. These findings reveal, for the first time to our knowledge, that RSK is the principal regulator of NHE1 phosphorylation and activity after α1-adrenergic stimulation in adult myocardium.
AB - Multiple stimuli of physiological and pathophysiological significance, including α1-adrenoceptor agonists, stimulate the cardiac sarcolemmal Na+/H+ exchanger isoform 1 (NHE1) through activation of the mitogen-activated or extracellular signal-regulated kinase (ERK) kinase (MEK) ERK-90-kDa ribosomal S6 kinase (RSK) signaling cascade. However, the individual contributions of ERK and RSK, which can each phosphorylate the NHE1 regulatory domain, to such stimulation are unknown. In the present study, we have used the novel RSK inhibitor fmk to determine the role of RSK as a direct regulator of NHE1 phosphorylation and activity in response to α1-adrenergic stimulation, in ventricular myocytes isolated from the adult rat heart. Initial experiments confirmed that pretreatment of myocytes with fmk before exposure to the α1- adrenoceptor agonist phenylephrine inhibited RSK C-terminal kinase activity and thereby RSK N-terminal kinase activation, without affecting MEK or ERK activation. Pretreatment of myocytes with fmk also inhibited phenylephrine-induced increases in NHE1 phosphorylation and the rate of NHE1-mediated H+ efflux under conditions of intracellular acidosis. These findings reveal, for the first time to our knowledge, that RSK is the principal regulator of NHE1 phosphorylation and activity after α1-adrenergic stimulation in adult myocardium.
UR - http://www.scopus.com/inward/record.url?scp=33847122150&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847122150&partnerID=8YFLogxK
U2 - 10.1124/mol.106.029900
DO - 10.1124/mol.106.029900
M3 - Article
C2 - 17142297
AN - SCOPUS:33847122150
SN - 0026-895X
VL - 71
SP - 799
EP - 806
JO - Molecular pharmacology
JF - Molecular pharmacology
IS - 3
ER -